Advances in Bevacizumab Therapy for Non-small Cell Lung Cancer 
with Brain Metastases

oleh: Liyan QU, Rui GENG, Xia SONG

Format: Article
Diterbitkan: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2016-08-01

Deskripsi

Brain metastases are frequently encountered in patients with non-small cell lung cancer (NSCLC) and are a significant cause of morbidity and mortality. Antiangiogenesis therapy plays a major role in the management of brain metastases in lung cancer. Bevacizumab have become the novel method for the treatment of lung cancer with brain metastases beyond the whole brain radiation therapy, stereotactic radiosurgery and chemotherapy. Recently, more and more studies and trials laid emphasis on the bevacizumab for NSCLC with brain metastases treatment. The key point is the efficacy and safety. In this review, bevacizumab therapy of NSCLC with brain metastases were summarized.